Femtobiomed Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2018	FY 2017
Period Ending	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Operating Revenue	389.95	395.57
Other Revenue	0	-
Revenue	389.96	395.57
Revenue Growth (YoY)	-1.42%	-
Cost of Revenue	270.88	252.88
Gross Profit	119.08	142.69
Selling, General & Admin	776.42	692.75
Research & Development	470.74	411.09
Other Operating Expenses	28.44	30.67
Operating Expenses	1,319	1,189
Operating Income	-1,200	-1,047
Interest Expense	-0.71	-2.39
Interest & Investment Income	3.78	8.66
Currency Exchange Gain (Loss)	0.9	-3.32
Other Non Operating Income (Expenses)	-13.93	-27.84
EBT Excluding Unusual Items	-1,210	-1,072
Gain (Loss) on Sale of Assets	-	1.63
Pretax Income	-1,210	-1,070
Net Income	-1,210	-1,070
Net Income to Common	-1,210	-1,070
Shares Outstanding (Basic)	1	1
Shares Outstanding (Diluted)	1	1
Shares Change (YoY)	0.06%	-
EPS (Basic)	-876.00	-775.00
EPS (Diluted)	-876.00	-775.00
Free Cash Flow	-1,233	-996.14
Free Cash Flow Per Share	-892.82	-721.51
Gross Margin	30.54%	36.07%
Operating Margin	-307.76%	-264.62%
Profit Margin	-310.32%	-270.50%
Free Cash Flow Margin	-316.28%	-251.83%
EBITDA	-1,075	-904.97
EBITDA Margin	-275.77%	-228.78%
D&A For EBITDA	124.75	141.76
EBIT	-1,200	-1,047
EBIT Margin	-	-264.62%
Advertising Expenses	11.23	10.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.